| Financial Year |
March 31 2022 |
| Monetary Funds |
160,854,271.45 |
| Held-for-trading Financial Assets |
624,841,900.00 |
| Notes Receivable |
9,562,701.63 |
| Accounts Receivable |
190,967,832.43 |
| Advances to Suppliers |
17,175,036.62 |
| Other Receivables |
6,806,052.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,107,606.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
183,239.87 |
| Total Current Assets |
1,108,136,446.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
43,814,456.22 |
| Under-construction Projects |
709,489.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,286,354.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,454.72 |
| Deferred Income Tax Assets |
6,551,413.42 |
| Other Non-Current Assets |
19,426,354.53 |
| Sub-Total of Non-Current Assets |
105,828,522.77 |
| Total Assets |
1,213,964,969.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,357,922.35 |
| Accounts Payable |
42,698,131.89 |
| Accounts Received In Advance |
372,140.06 |
| Employee Compensation Payable |
6,714,446.33 |
| Taxes Payable |
17,431,147.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,856.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
102,989,555.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
576,285.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
576,285.00 |
| Total Liabilities |
103,565,840.32 |
| Paid-In Capital(Or Share Stock) |
139,280,000.00 |
| Capital Surplus |
541,611,190.61 |
| Surplus Reserve |
42,242,744.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
378,791,695.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,110,399,129.27 |
| Owner's Equity（Stockholder's Equity） |
1,110,399,129.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,213,964,969.59 |
